Amrutanjan Health Care Share Price Today (AMRUTANJAN)
TODAY IN ONE LINE
AMRUTANJAN fell 1.2% on light volume, in line with Nifty's -0.7% move.
With a market cap of ₹1,533.42 Cr., it trades at a P/E of 26.90. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Amrutanjan Health Care flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Capital EfficiencyROCE of 31.4% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 20.0%
- ●Healthy Operating MarginsOPM is structurally strong at 17.7%
- ●Steady Dividend YieldReliable 1.02% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 14.6% outpacing sales growth of 7.3%
Latest Amrutanjan Health Care News
What changed recently?
Recent events, corporate actions, and announcements.
Amrutanjan Health Care Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Amrutanjan Health Care Limited, framed against the sector median so the premium or discount is obvious at a glance.
Amrutanjan Health Care Limited trades at a P/E of 26.90× and P/B of 4.21×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Amrutanjan Health Care Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Amrutanjan Health Care Limited — derived from the live tape, not yesterday's close.
Amrutanjan Health Care Limited last traded at ₹532.05 with an intraday range of ₹530.1–₹538.6 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹532.05| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 554.07 | +22.02 | +4.14% |
| R3 | 545.57 | +13.52 | +2.54% |
| R2 | 542.08 | +10.03 | +1.89% |
| R1 | 537.07 | +5.02 | +0.94% |
| PIVOT | 533.58 | 1.53 | 0.29% |
| CURRENT | 532.05 | — | — |
| S1 | 528.57 | -3.48 | -0.65% |
| S2 | 525.08 | -6.97 | -1.31% |
| S3 | 520.07 | -11.98 | -2.25% |
| S4 | 511.57 | -20.48 | -3.85% |
AMRUTANJAN is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹535–₹538.6
Trading Below opening range, showing Bearishness
Amrutanjan Health Care Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Amrutanjan Health Care Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Amrutanjan Health Care Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,533.42 Cr. and reported EPS of ₹20.01.
Amrutanjan Health Care segment analysis : revenue and profit mix.
Disclosed business segments at Amrutanjan Health Care with their share of revenue and profit, switchable between consolidated and standalone reporting.
Amrutanjan Health Care discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Amrutanjan Health Care Limited.
Our AI distills the core fundamental drivers supporting Amrutanjan Health Care Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Amrutanjan Health Care Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Robust ROCE of 31.40% demonstrates superior capital efficiency versus sector peers.
Fortress balance sheet with debt-to-equity ratio of 0.0002 and negative net debt.
Strong operating margin of 12.29% with net margin of 11.52% exceed peer averages.
Latest quarterly EPS grew 6.7% YoY despite modest revenue base and market cap.
Substantial cash reserves of ₹2,074.63 Cr support dividends and strategic investments.
Key Risks.
5-year revenue CAGR of 0% and 5-year EPS CAGR of 0% indicate prolonged earnings stagnation.
High P/E valuation of 27.42x TTM relative to modest growth trajectory limits upside potential.
Operating cash flow of ₹35.97 Cr converts only 62% of net profit; below peer norms of 80%+.
Modest dividend yield of 0.86% with payout ratio of 22.97% provides limited income appeal.
52-week price range of ₹486–₹790.95 reflects significant volatility without directional momentum.
Flip Conditions.
Valuation risk. a P/E above 35 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 15% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.51%.
Amrutanjan Health Care Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Amrutanjan Health Care Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Amrutanjan Health Care Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Amrutanjan Health Care Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Amrutanjan Health Care Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Amrutanjan Health Care Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Amrutanjan Health Care Limited stood at 66.9% of traded volume, against a 20-day average of 60.0%.
Amrutanjan Health Care announcements: results, concalls, ratings, M&A.
Filings Amrutanjan Health Care sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Amrutanjan Health Care files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 49 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Trading Window
Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Updates
Amrutanjan Health Care Limited has informed the Exchange regarding 'Financial Results-Machine Readable Format'.
Investor Presentation
Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
Dividend
Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of…
Investor decks & rating reports.
Amrutanjan Health Care dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Amrutanjan Health Care has declared, sequenced by announce and record date.
Amrutanjan Health Care corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Amrutanjan Health Care insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Amrutanjan Health Care as reported to SEBI — buying and selling signals from the people who know the business best.
Amrutanjan Health Care insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| S Jeyakanth | Insider | 28 May 2025 | sell | −1.4 K | ₹10.03 L | ₹716.28 |
About Amrutanjan Health Care Limited: business, sector, key facts.
What Amrutanjan Health Care Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Amrutanjan Health Care Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: AMRUTANJAN, BSE: 590006.
Amrutanjan Health Care Limited is a prominent Indian company specializing in the manufacture, supply, and sale of Ayurvedic pain relief balms and women's hygiene products. Established in 1893 and headquartered in Chennai, the company has a long history of providing healthcare solutions. Originally known as Amrutanjan Limited, it rebranded to its current name in 2007, reflecting its expansion beyond its core product line.
The company's business is segmented into three key areas: OTC (Over-the-Counter) Products, Beverages, and Others. The OTC Products segment is the largest, encompassing a wide range of pain management solutions. This includes various pain balms and roll-ons targeting different pain types (back pain, body pain, joint pain), as well as stick-on patches, gels, and sprays. Furthermore, they offer congestion management products such as cold rubs, cough syrups, nasal inhalers, and throat lozenges. Their women's hygiene product line features sanitary napkins.
Beyond pain relief and women's health, Amrutanjan also operates in the beverage sector under the Fruitnik and Fruitnik Electro+ brands, offering juice drinks. The "Others" segment encompasses a diverse array of products including corn caps, dental gel, and hand sanitizers. Interestingly, the company also manages a pain management center, demonstrating a commitment to comprehensive healthcare services.
Amrutanjan's reach extends beyond the domestic Indian market, with significant export activities to various regions globally. These export markets include the Middle East, Africa, and Southeast Asia, highlighting the international appeal of their products and brand reputation. The company's success stems from a blend of traditional Ayurvedic formulations and modern manufacturing practices, catering to a broad consumer base seeking effective and accessible healthcare solutions.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs and Pharmaceuticals (AKUMS) Share PricePeer
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Amrutanjan Health Care Limited (AMRUTANJAN).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Amrutanjan Health Care Limited (AMRUTANJAN)?
The current share price of Amrutanjan Health Care Limited (AMRUTANJAN) is ₹532.05. Today, the stock has declined by ₹6.55 (1.22%), trading in a range of ₹530.1 to ₹538.6. The stock opened at ₹538.6 with a trading volume of 18,710 shares.
02Is Amrutanjan Health Care Limited stock a good investment for long-term?
Amrutanjan Health Care Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,533.42 crores, P/E ratio of 26.90, ROE of 20.00%, and ROCE of 31.40%. The dividend yield stands at 1.02%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Amrutanjan Health Care Limited stock?
The 52-week high price of Amrutanjan Health Care Limited (AMRUTANJAN) is ₹790.95, while the 52-week low is ₹486. Currently trading at ₹532.05, the stock is 15.1% away from its 52-week low and 32.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Amrutanjan Health Care Limited stock at the current price?
Whether to buy Amrutanjan Health Care Limited stock at ₹532.05 depends on multiple factors. The stock is currently trading with a P/E ratio of 26.90 and P/B ratio of 4.21. Today's performance shows a loss of 1.22%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Amrutanjan Health Care Limited and when is the next dividend?
Amrutanjan Health Care Limited offers a dividend yield of 1.02%, which means for every ₹100 invested at the current price of ₹532.05, you can expect to receive approximately ₹1.02 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Amrutanjan Health Care Limited?
Amrutanjan Health Care Limited's key financial metrics include: P/E Ratio: 26.90, P/B Ratio: 4.21, ROE: 20.00%, ROCE: 31.40%, Dividend Yield: 1.02%, EPS: ₹20.01, Book Value: ₹128.04, and Debt-to-Equity: 0.02. The company's market cap stands at ₹1,533.42 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Amrutanjan Health Care Limited stock performing today in the market?
Amrutanjan Health Care Limited stock opened at ₹538.6 and is currently trading at ₹532.05, showing a decline of ₹6.55 (1.22%). The intraday high is ₹538.6 and low is ₹530.1. The trading volume stands at 18,710 shares, indicating moderate market participation today.
08What is the P/E ratio of Amrutanjan Health Care Limited and what does it indicate?
Amrutanjan Health Care Limited has a Price-to-Earnings (P/E) ratio of 26.90, which means investors are willing to pay ₹26.90 for every ₹1 of earnings. With an EPS of ₹20.01, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Amrutanjan Health Care Limited (AMRUTANJAN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.